Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea
Hong Sun, John Palcza, Deborah Card, et al.
Journal of Clinical Sleep Medicine (2016) Vol. 12, Iss. 01, pp. 9-17
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Review of Safety and Efficacy of Sleep Medicines in Older Adults
Jennifer Schroeck, James M. Ford, Erin Conway, et al.
Clinical Therapeutics (2016) Vol. 38, Iss. 11, pp. 2340-2372
Open Access | Times Cited: 308
Sleep disorders in the elderly: Diagnosis and management
Keisuke Suzuki, Masayuki Miyamoto, Koichi Hirata
Journal of General and Family Medicine (2017) Vol. 18, Iss. 2, pp. 61-71
Open Access | Times Cited: 201
International Consensus Statement on Obstructive Sleep Apnea
Jolie L. Chang, Andrew N. Goldberg, Jeremiah A. Alt, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 7, pp. 1061-1482
Open Access | Times Cited: 159
Insomnia in Elderly Patients: Recommendations for Pharmacological Management
Vivien C. Abad, Christian Guilleminault
Drugs & Aging (2018) Vol. 35, Iss. 9, pp. 791-817
Closed Access | Times Cited: 139
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Akira Kuriyama, Hiromitsu Tabata
Sleep Medicine Reviews (2016) Vol. 35, pp. 1-7
Closed Access | Times Cited: 133
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020
Tsuneto Akashiba, Yuichi Inoue, Naohisa Uchimura, et al.
Respiratory Investigation (2022) Vol. 60, Iss. 1, pp. 3-32
Open Access | Times Cited: 40
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Kayla Janto, J. Roxanne Prichard, Snigdha Pusalavidyasagar
Journal of Clinical Sleep Medicine (2018) Vol. 14, Iss. 08, pp. 1399-1408
Open Access | Times Cited: 81
Effects of orexin receptor antagonism on human sleep architecture: A systematic review
Jacob Clark, Maddison L. Brian, Sean P. A. Drummond, et al.
Sleep Medicine Reviews (2020) Vol. 53, pp. 101332-101332
Closed Access | Times Cited: 54
Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H. James, Jennifer E. Fragale, R. Nisha Aurora, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 5, pp. 717-719
Open Access | Times Cited: 51
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 47
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Pharmacological Treatment of Insomnia
Paula K. Schweitzer, Stephen D. Feren
Springer eBooks (2016), pp. 97-132
Closed Access | Times Cited: 58
Prescription Drugs Used in Insomnia
Sylvie Dujardin, Angelique Pijpers, Dirk Pevernagie
Sleep Medicine Clinics (2020) Vol. 15, Iss. 2, pp. 133-145
Closed Access | Times Cited: 39
Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study
Jocelyn Y. Cheng, Gleb Filippov, Margaret Moline, et al.
Journal of Sleep Research (2020) Vol. 29, Iss. 4
Open Access | Times Cited: 39
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases
Alberto Giannoni, Chiara Borrelli, Francesco Gentile, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 5, pp. 642-656
Open Access | Times Cited: 15
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway
Bruce Corser, Erica Eves, Jennifer Warren-McCormick, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 6, pp. 1035-1042
Open Access | Times Cited: 13
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Shahrokh Javaheri, Sogol Javaheri, David Gozal, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 13, pp. 1224-1240
Closed Access | Times Cited: 5
Obstructive sleep apnea syndrome, orexin, and sleep–wake cycle: The link with the neurodegeneration
Mariana Fernandes, Claudio Liguori
Handbook of clinical neurology (2025), pp. 141-160
Closed Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Page 1 - Next Page

Scroll to top